Research Topic

Novel Biomarkers for Type 2 Diabetes

About this Research Topic

Type 2 diabetes (T2D) is one of the most prevalent chronic diseases, affecting about 415 million people worldwide in 2015. The etiology of T2D involves an interaction between genetic predisposition and lifestyle (e.g. overweight, unhealthy diet, sedentariness).

The past decade has seen fast-paced, technology-driven developments in the field of complex disease genomics. Implementation of the genome wide association study approach has revolutionized our understanding of the genetic underpinnings of T2D, identifying ~70 genetic risk loci for T2D. However, these alone explain less than 10% of overall T2D risk and do not accurately predict T2D.

In the past five years, clinical studies of T2D have increasingly focused on identifying novel serum biomarkers for T2D using cutting-edge ‘omics’ tools, such as metabolomics and proteomics. Metabolomics approaches in particular have been widely adapted to screen blood or other human tissues for changes in metabolites and low-molecular-weight biomolecules such as lipids, sugars, amino acids, organic acids, and nucleotides.

We welcome original and review papers describing current highlights, methods, and challenges in identifying, characterizing, and validating “Novel Biomarkers for Type 2 Diabetes”. We welcome both basic and clinical research articles focusing on experimental data and/or theory including (but not limited to) the following potential topics:
• Identification of biomarkers (e.g. genetic, metabolomic, or proteomic) associated with T2D and related traits
• Prediction of incident T2D and related traits using multivariate models that combine biomarkers and other predictors in data from clinical trials or prospective cohort studies
• Integrative approaches for biomarkers and/or ‘omics’ to improve T2D risk prediction based on existing or new data


Keywords: Biomarkers, diabetes, genetics, metabolomic


Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

Type 2 diabetes (T2D) is one of the most prevalent chronic diseases, affecting about 415 million people worldwide in 2015. The etiology of T2D involves an interaction between genetic predisposition and lifestyle (e.g. overweight, unhealthy diet, sedentariness).

The past decade has seen fast-paced, technology-driven developments in the field of complex disease genomics. Implementation of the genome wide association study approach has revolutionized our understanding of the genetic underpinnings of T2D, identifying ~70 genetic risk loci for T2D. However, these alone explain less than 10% of overall T2D risk and do not accurately predict T2D.

In the past five years, clinical studies of T2D have increasingly focused on identifying novel serum biomarkers for T2D using cutting-edge ‘omics’ tools, such as metabolomics and proteomics. Metabolomics approaches in particular have been widely adapted to screen blood or other human tissues for changes in metabolites and low-molecular-weight biomolecules such as lipids, sugars, amino acids, organic acids, and nucleotides.

We welcome original and review papers describing current highlights, methods, and challenges in identifying, characterizing, and validating “Novel Biomarkers for Type 2 Diabetes”. We welcome both basic and clinical research articles focusing on experimental data and/or theory including (but not limited to) the following potential topics:
• Identification of biomarkers (e.g. genetic, metabolomic, or proteomic) associated with T2D and related traits
• Prediction of incident T2D and related traits using multivariate models that combine biomarkers and other predictors in data from clinical trials or prospective cohort studies
• Integrative approaches for biomarkers and/or ‘omics’ to improve T2D risk prediction based on existing or new data


Keywords: Biomarkers, diabetes, genetics, metabolomic


Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

About Frontiers Research Topics

With their unique mixes of varied contributions from Original Research to Review Articles, Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author.

Topic Editors

Loading..

Submission Deadlines

30 November 2017 Manuscript
31 December 2017 Manuscript Extension

Participating Journals

Manuscripts can be submitted to this Research Topic via the following journals:

Loading..

Topic Editors

Loading..

Submission Deadlines

30 November 2017 Manuscript
31 December 2017 Manuscript Extension

Participating Journals

Manuscripts can be submitted to this Research Topic via the following journals:

Loading..
Loading..

total views article views article downloads topic views

}
 
Top countries
Top referring sites
Loading..

Comments

Loading..

Add a comment

Add comment
Back to top